Exact Mass: 309.0362
Exact Mass Matches: 309.0362
Found 243 metabolites which its exact mass value is equals to given mass value 309.0362,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glymidine
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BC - Sulfonamides (heterocyclic) C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent
Indoxyl glucuronide
Indoxyl glucuronide is a natural human metabolite of indoxyl generated in the liver by UDP-glucuronyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs, and other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Indoxyl glucuronide has been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821). Inodxyl glucuronide is a natural human metabolite of Inodxyl generated in the liver by UDP glucuonyltransferase.
N-Feruloylaspartic acid
N-Feruloylaspartic acid is found in root vegetables. N-Feruloylaspartic acid is a constituent of beet (Beta vulgaris). Constituent of beet (Beta vulgaris). N-Feruloylaspartic acid is found in root vegetables.
Glycodiazine
Glycodiazine is used with diet to lower blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin. The mechanism of action of glycodiazine in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glycodiazine likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. It is used for the concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BC - Sulfonamides (heterocyclic) C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent
Lamivudine-monophosphate
Lamivudine-monophosphate is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia)
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid is a metabolite of mefloquine. Mefloquine hydrochloride (also known as Lariam or Mefaquin) is an orally administered medication used in the prevention and treatment of malaria. Mefloquine was developed in the 1970s at the United States Department of Defenses Walter Reed Army Institute of Research as a synthetic analogue of quinine. The brand name drug, Lariam, is manufactured by the Swiss company Hoffmann–La Roche. In August 2009, Roche stopped marketing Lariam in the United States. (Wikipedia)
Hydroxylumiracoxib
Hydroxylumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)
3-oxobrimonidine
3-oxobrimonidine is a metabolite of brimonidine. Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form. (Wikipedia)
Glucose aspartate
N(4)-Acetylsulfisoxazole
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
methyl 1-(4-chlorophenyl)-5-(2-methoxy-2-oxoethyl)-1H-1,2,3-triazole-4-carboxylate
4-(5-Cyano-1H-1,2,3-triazol-4-yl)phenyl 3,5-dimethylisoxazole-4-carboxylate
(-)-N-[3,4-Dihydroxy-(E)-cinnamoyl]-L-glutamic acid
2-Hydroxy-1-methoxy-4-oxo-4,5-dihydrodibenzo[cd,f]indole-3-carboxylic acid
3-<(5-isobutyl-1,2,4-trithiolane-3-yl)methyl>indole
(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)butan-1-imine
2-[(3,6-dihydroxy-5-methoxy-7-methyl-4-oxochromen-2-yl)amino]propanoic acid
2,8-BIS(TRIFLUROMETHYL)-4-QUINOLINCARBOXYLIC ACID
2-(2-Benzenesulfonamido-5-pyrimidinyloxy)acetic acid
1-cyclopropyl-8-ethoxy-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
ethyl 6-bromo-8-methyl-4-oxo-1H-quinoline-3-carboxylate
7-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
5-(CHLOROMETHYL)-2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOLE
3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine
METHYL 3-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-2-CARBOXYLATE
2-[4-[5-chloro-3-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]ethanol
TERT-BUTYL 3-BROMO-7-METHYL-1H-INDOLE-1-CARBOXYLATE
Ethyl1-(5-bromopyridin-2-yl)-5-methylpyrazole-4-carboxylate
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carboxylic acid
3-(3-bromopyridin-2-yl)-3,9-diazaspiro[5.5]undecane
2,5-Cyclohexadien-1-one,4-[[4-(acetyloxy)phenyl]imino]-2,6-dichloro-
4-(2,4-difluorophenoxy)-n-hydroxy-3-nitrobenzenecarboximidamide
(4-((2-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)PHENYL)BORONIC ACID
ETHYL5-AMINO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
Ethyl (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate
3-(Boc-amino)-6,6-dichlorobicyclo[3.1.0]hexane-3-carboxylic Acid
METHYL 2-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-3-CARBOXYLATE
METHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE- 2-CARBOXYLATE
[2-(3-bromo-phenyl)-ethyl]-(4-chloro-phenyl)-amine
2-AMINO-4-(3,4-DIFLUOROPHENYL)-5H-INDENO[1,2-D]PYRIMIDIN-5-ONE
ETHYL 5-AMINO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
3-(3H-imidazol-4-yl)-2-[(4-methylphenyl)sulfonylamino]propanoic acid
TERT-BUTYL 5-(BROMOMETHYL)-1H-INDOLE-1-CARBOXYLATE
2-[2-(2-amino-1,3-thiazol-4-yl)ethyl]isoindole-1,3-dione,hydrochloride
Acetic acid, [4-[(2,4-dioxo-5-thiazolidinyl)methyl]phenoxy]-, ethyl ester
Sulfisoxazole Acetyl
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
tert-butyl 4-(bromomethyl)-1H-indole-1-carboxylate
1H-Benzimidazole,5-[5-[(3-pyridinylmethyl)thio]-1,3,4-oxadiazol-2-yl]-(9CI)
2-[4-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDYL]PIPERAZINO]ETHAN-1-OL
2-[2-(1-bromonaphthalen-2-yl)oxyethylamino]ethanol
3-Chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-ol 5,5-dioxide
1H-Benzimidazole,5-[5-[(4-pyridinylmethyl)thio]-1,3,4-oxadiazol-2-yl]-(9CI)
ethyl (E)-3-(2-chloro-6-fluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate
4-ISOXAZOLECARBOXYLIC ACID, 5-(4-BROMOPHENYL)-3-METHYL-, ETHYL ESTER
TERT-BUTYL 7-(BROMOMETHYL)-1H-INDOLE-1-CARBOXYLATE
(Z)-1-phenyl-2-(bromomethyl)-N,N-diethylcyclopropanecarboxamide
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
2-(4-chloro-2-methylphenoxy)-N-(2-chlorophenyl)acetamide
5-bromo-N-cyclopentyl-2-(trifluoromethyl)pyrimidin-4-amine
1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic acid ethyl ester
4-[[(4-CHLORO-2,5-DIMETHYLPHENYL)SULFONYL]METHYL]ANILINE
methyl (2S)-2-(2-chlorophenyl)-2-(2-thiophen-2-ylethylamino)acetate
4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZENECARBOXYLIC ACID
(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)boronic acid
5-(5-Methoxy-2-(trifluoromethyl)-1H-benzo[d]imidazol-1-yl)pyrazin-2-amine
(2,3,4,5,6-pentafluorophenyl) 1-methylpiperidine-3-carboxylate
3-(5-bromopyridin-2-yl)-3,9-diazaspiro[5.5]undecane
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-, ETHYL ESTER
Brofaromine
D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Irosustat
C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor
5-Hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.
N-(5-chloro-2-pyridinyl)-2-(3,5-dimethyl-4-nitro-1-pyrazolyl)acetamide
6-Amino-5-[(4-chlorophenyl)sulfonyl]-2-hydroxynicotinonitrile
2-Chloro-1-[1-[2-(4-chlorophenyl)ethyl]-2,5-dimethyl-3-pyrrolyl]ethanone
N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide
7-Chloro-4-[4-(2-chloroethyl)-1-piperazinyl]quinoline
6-(2-Furanyl)-3-(2-pyridinylmethylthio)-[1,2,4]triazolo[4,3-b]pyridazine
1-[[2-(1H-benzimidazol-2-ylthio)-1-oxoethyl]amino]-3-ethylthiourea
2-[[(1-Phenyl-5-tetrazolyl)thio]methyl]imidazo[1,2-a]pyrimidine
1-Methyl-3-trifluoromethyl-1H-thieno[2,3-C]pyrazole-5-carboxylic acid (2-mercapto-ethyl)-amide
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]formamide
(2R)-2-amino-3-(6-chloro-2-phenylpyrimidin-4-yl)sulfanylpropanoic acid
(2R)-2-amino-3-(1H-indol-3-ylmethylcarbamothioylsulfanyl)propanoic acid
8-amino-3,4,4a,10a-tetrahydroxy-2-(hydroxymethyl)-3,4,7,8-tetrahydro-2H-pyrano[2,3-b][1,4]dioxocine-6,9-dione
N-(4-tert-butyl-2-thiazolyl)-4-chlorobenzohydrazide
5-(4-methylpiperazin-1-yl)sulfonyl-1H-indole-2,3-dione
6-[[(2-Methoxycarbonyl-3-thiophenyl)amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid
N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide
2-[(2-pyridinylthio)methyl]-1H-benzofuro[3,2-d]pyrimidin-4-one
N-[5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamic acid ethyl ester
N-[(E)-(3-nitrophenyl)methylideneamino]-1-benzofuran-2-carboxamide
4,5-Dimethyl-2-[[oxo(thiophen-2-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester
N-[5-(ethoxymethyl)-1,3,4-thiadiazol-2-yl]-2-(phenylthio)acetamide
2-(2-methoxyethylthio)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide
Phenguignardate
A monocarboxylic acid anion that is the conjugate base of phenguignardic acid, obtained from the derotonation of the carboxy group. Major species at pH 7.3.
4-[(E)-[[5-(Trifluoromethyl)pyridin-2-yl]hydrazinylidene]methyl]benzoic acid
(2Z)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)methylidene]-4-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-3-olate
2-[(3,6-Dihydroxy-5-methoxy-7-methyl-4-oxochromen-2-yl)amino]propanoic acid
3H-isoindol-1-yl (3S,4S,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carboxylate
4-hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 4-hydroxylation followed by oxidation.
1h-indol-3-yl (2r,3s,4s,5r)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolane-2-carboxylate
3-bromo-4-(2-imino-1,3-dihydroimidazol-4-yl)-1h,4h,5h,6h-pyrrolo[2,3-c]azepin-8-ol
(2s,3r,4s,4ar,11br)-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-2,3,4,6,7-pentol
aristolactam c ii; 1'-carboxylic acid,o2-de-me
{"Ingredient_id": "HBIN016768","Ingredient_name": "aristolactam c ii; 1'-carboxylic acid,o2-de-me","Alias": "NA","Ingredient_formula": "C17H11NO5","Ingredient_Smile": "NA","Ingredient_weight": "309.27","OB_score": "NA","CAS_id": "106283-33-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6676","PubChem_id": "NA","DrugBank_id": "NA"}
